1. Baldoni S, Del Papa B, De Falco F, et al. Notch1 activation
negatively impacts on chronic lymphocytic leukemia outcome and is not
correlated to the notch1 and ighv mutational status. Front Oncol
2021;11:668573.
2. Woyach JA. What is the optimal management of older cll patients? Best
Pract Res Clin Haematol 2018;31(1):83-89.
3. Woyach JA. Treatment-naive cll: Lessons from phase 2 and phase 3
clinical trials. Blood 2019;134(21):1796-1801.
4. Quinquenel A, Aurran-Schleinitz T, Clavert A, et al. Diagnosis and
treatment of chronic lymphocytic leukemia: Recommendations of the french
cll study group (filo). Hemasphere 2020;4(5):e473.
5. Vitale C, Montalbano MC, Salvetti C, et al. Autoimmune complications
in chronic lymphocytic leukemia in the era of targeted drugs. Cancers
(Basel) 2020;12(282). 10.3390/cancers12020282.
6. Singal R, Winfield DA, Greaves M. Bone marrow aplasia in b cell
chronic lymphocytic leukaemia: Successful treatment with antithymocyte
globulin. J Clin Pathol 1991;44(11):954-956.
7. Zonder JA, Keating M, Schiffer CA. Chronic lymphocytic leukemia
presenting in association with aplastic anemia. Am J Hematol
2002;71(4):323-327.
8. Hochman MJ, Martin DB. Coincidence of autoimmune hemolytic anemia and
pure red cell aplasia in a patient with cll. Ann Hematol
2021;100(2):579-580.
9. Reinart N, Nguyen PH, Boucas J, et al. Delayed development of chronic
lymphocytic leukemia in the absence of macrophage migration inhibitory
factor. Blood 2013;121(5):812-821.
10. Wherry EJ. T cell exhaustion. Nat Immunol 2011;12(6):492-499.
11. Forconi F, Moss P. Perturbation of the normal immune system in
patients with cll. Blood 2015;126(5):573-581.
12. Lad D, Hoeppli R, Huang Q, et al.
Regulatory
t-cells drive immune dysfunction in cll. Leuk Lymphoma
2018;59(2):486-489.
13. Wright SJ, Keating MJ. Cyclosporine a in chronic lymphocytic
leukemia: Dual anti-leukemic and immunosuppressive role? Leuk Lymphoma
1995;20(1-2):131-136.
14. Zhao X, Zhou K, Jing L, et al. Treatment of t-cell large granular
lymphocyte leukemia with cyclosporine a: Experience in a chinese single
institution. Leuk Res 2013;37(5):547-551.